Humana (HUM) Stock Price, News & Analysis

Company Overview

Humana Inc. (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination. The company works through networks of clinicians, hospitals and pharmacies and has developed programs to integrate medical and pharmacy benefits, promote value-based arrangements with providers, and deliver services in community and home settings. Humana also operates initiatives aimed at addressing social determinants of health and improving access to health services for its members.

Humana’s operations are focused on the U.S. market and include product offerings for Medicare, Medicaid-managed care, and employer-sponsored plans where applicable. The company has been shifting toward integrated, value-based care models and partnerships with provider organizations to enhance care continuity and control costs. It also invests in technology and analytics to support population health management and member engagement.

Humana is publicly traded on the New York Stock Exchange under the ticker HUM. Bruce D. Broussard serves as president and chief executive officer, leading the company’s strategic focus on senior care, value-based provider relationships and expanding services that support members beyond traditional insurance coverage.

Key Stats

• Today's Range: $302.09 to $313.19
• 50-Day Range: $163.80 to $305.59
• 52-Week Range: $163.11 to $315.35
• Volume: 1.18 million shs
• Average Volume: 2.00 million shs
• Market Capitalization: $37.20 billion
• P/E Ratio: 33.14
• Dividend Yield: 1.14%
• Price Target: $249.91
• Consensus Rating: Hold

Humana Stock Analysis - MarketRank™

Humana scored higher than 75% of companies evaluated by MarketBeat, and ranked 235th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

Humana has received a consensus rating of Hold. The company's average rating score is 2.15, and is based on no strong buy ratings, 7 buy ratings, 16 hold ratings, and 3 sell ratings.

Downside Risk

Humana has a consensus price target of $249.91, representing about 19.6% downside from its current price of $310.92.

Amount of Analyst Coverage

Humana has been the subject of 19 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 64.00%

Earnings Growth

Earnings for Humana are expected to grow by 64.00% in the coming year, from $9.00 to $14.76 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Humana is 33.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.43.

Price to Earnings Ratio vs. Sector

The P/E ratio of Humana is 33.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.61.

Price to Earnings Growth Ratio

Humana has a PEG Ratio of 2.84. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Humana has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.24% of the float of Humana has been sold short.

Short Interest Ratio / Days to Cover

Humana has a short interest ratio ("days to cover") of 3.05, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Humana has recently increased by 15.72%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Humana pays a meaningful dividend of 1.16%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Humana does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Humana is 37.86%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Humana will have a dividend payout ratio of 23.98% next year. This indicates that Humana will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 0.56

News Sentiment

Humana has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.37 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 33 news articles for Humana this week, compared to 11 articles on an average week.

Search Interest

23 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 44% compared to the previous 30 days.

MarketBeat Follows

6 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 2.2 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Humana insiders have bought more of their company's stock than they have sold. Specifically, they have bought $150,020.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

0.20% of the stock of Humana is held by insiders.

Percentage Held by Institutions

92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 4/24 Dividend: 3/27/2026
• Ex-Dividend for 4/24 Dividend: 3/27/2026
• Dividend Payable: 4/24/2026
• Last Earnings: 4/29/2026
• Today: 5/19/2026
• Next Earnings (Estimated): 7/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:HUM
• CIK: 49071
• Web: www.humana.com
• Phone: (502) 580-1000
• Fax: 502-580-3639
• Employees: 67,060
• Year Founded: 1961

Price Target and Rating

• Average Price Target for Humana: $249.91
• High Price Target: $344.00
• Low Price Target: $180.00
• Potential Upside/Downside: -19.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.15
• Research Coverage: 26 Analysts

Profitability

• EPS (Trailing Twelve Months): $9.35
• Trailing P/E Ratio: 33.16
• Forward P/E Ratio: 34.42
• P/E Growth: 2.84
• Net Income: $1.19 billion
• Net Margins: 0.82%
• Pretax Margin: 1.06%
• Return on Equity: 10.45%
• Return on Assets: 3.75%

Debt

• Debt-to-Equity Ratio: 0.66
• Current Ratio: 1.77
• Quick Ratio: 1.77

Sales & Book Value

• Annual Sales: $129.66 billion
• Price / Sales: 0.29
• Cash Flow: $24.43 per share
• Price / Cash Flow: 12.68
• Book Value: $147.47 per share
• Price / Book: 2.10

Miscellaneous

• Outstanding Shares: 120,060,000
• Free Float: 119,822,000
• Market Cap: $37.19 billion
• Optionable: Optionable
• Beta: 0.68